Skip to main content
Year archive

Theranexus — 2025 filings

All 28 regulatory filings released by Theranexus (ALTHX) in 2025, sourced directly from the official regulator.

28 Filings
2025 Period
2025 filings (28)
Filing Released Lang
THX Pharma announces the strong success of its approximately EUR 8 million capital increase to support its continued development and strengthen its financial structure
Share Issue/Capital Change
2025-11-13 English
THX Pharma annonce le vif succès de son augmentation de capital d'environ 8M EUR pour poursuivre son développement et renforcer sa structure financière
Share Issue/Capital Change
2025-11-13 French
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change
2025-11-07 French
THX Pharma annonce le lancement d'une augmentation de capital avec maintien du DPS d'un montant d'environ 8M EUR
Capital/Financing Update
2025-10-23 French
THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
Capital/Financing Update
2025-10-23 English
THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01
Regulatory Filings
2025-10-14 English
THX PHARMA (THERANEXUS) ET EXELTIS FRANCHISSENT UNE ÉTAPE MAJEURE VERS LA COMMERCIALISATION DE TX01
Regulatory Filings
2025-10-14 French
Theranexus devient THX Pharma : une évolution stratégique vers la commercialisation de ses médicaments dans les maladies rares
Regulatory Filings
2025-09-29 French
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
Regulatory Filings
2025-09-29 English
THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2025
Earnings Release H1 2025
2025-09-25 French
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Earnings Release H1 2025
2025-09-25 English
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Transaction in Own Shares
2025-07-17 French
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025
Net Asset Value
2025-07-10 English
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2025
Earnings Release H1 2025
2025-07-10 French
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Regulatory Filings
2025-05-13 English
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE RÉELLE TRÈS POSITIVES SOUTENANT L'EFFICACITÉ DE BATTEN-1 DANS LE TRAITEMENT DE LA MALADIE DE BATTEN CLN3
Earnings Release Q2 2025
2025-05-13 French
URD 2024
Audit Report / Information FY 2024
2025-04-29 French
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Earnings Release FY 2024
2025-04-29 English
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Earnings Release FY 2024
2025-04-29 French
MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Regulatory Filings
2025-03-06 French
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Regulatory Filings
2025-01-31 French
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2024 ET FAIT LE POINT SUR SES ACTIVITÉS
Earnings Release FY 2024
2025-01-30 French
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT
Earnings Release FY 2024
2025-01-30 English
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
Report Publication Announcement
2025-01-23 English
THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025
Report Publication Announcement
2025-01-23 French
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements
2025-01-16 French
THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
Report Publication Announcement
2025-01-09 English
THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES
Report Publication Announcement
2025-01-09 French